The impact of chia seeds on diabetes, blood pressure, lipid profile, and obesity indicators: Systematic review and meta-regression analysis of 14 randomized controlled trials.
Autor: | Fateh HL; Nursing Department, Kalar Technical Institute, Garmian Polytechnic University, Kalar, Iraq., Ahmed DH; Nursing Department, Halabja Technical Institute, Sulaimani Polytechnic University, Sulaimani, Iraq., Najafabadi MS; Department of Nutritional Sciences, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Islamic Republic of Iran., Moludi J; Department of Nutritional Sciences, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Islamic Republic of Iran. Electronic address: jmoludi@yahoo.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2024 Dec; Vol. 175, pp. 106907. Date of Electronic Publication: 2024 Sep 19. |
DOI: | 10.1016/j.prostaglandins.2024.106907 |
Abstrakt: | This comprehensive systematic review and meta-analysis sought to investigate the impact of chia seed supplementation on obesity indicators and metabolic factors. Through a thorough search of relevant studies up to April 2024, 14 clinical trials involving 835 participants were included in the analysis. The findings revealed a notable decrease in triglyceride levels across both higher and lower doses of chia seeds, with weighted mean differences (WMD) of -8.69 mg/dL and -13.11 mg/dL, respectively. Additionally, a statistically significant reduction in LDL-C levels was observed solely in the higher dosage group, showing a WMD of -4.77 mg/dL. Moreover, although the decrease in systolic blood pressure (-2.78 mmHg) compared to the control group was statistically significant, it was only observed with the higher dosage. These results suggest that chia supplementation may offer beneficial effects on dyslipidemia, hypertension, and body weight, potentially mitigating the risk of cardiovascular disease. Competing Interests: Conflicts of Interest The authors declare no conflict of interest. (Copyright © 2024 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |